EVALUATION OF THE EFFICACY AND TOLERABILITY OF 7-AND 10-DAY STANDARD TRIPLE THERAPY FOR PATIENTS WITH DISEASES INDUCED BY <i>H. PYLORI</i>
The importance of the discussed problems caused by the wide spread stew of the disease associated with Helicobacter infection is described in the article. In Russia, H. pylori affects approximately 80% of adults. The aim of this study was to evaluate the efficacy and tolerability of H. pylori eradication in patients with H. pylori-induced diseases using 7- and 10-day triple therapy based on clarithromycin. The study included 60 patients with a positive result of detection of H. pylori with one of the invasive or non-invasive methods of diagnosis. The result demonstrated that the efficacy of 7 - and 10-day standard triple therapy, consisting of IPP, clarithromycin and amoxicillin the same and amounted up to 85,7%.